BCL2 and neoplasm: Our data showed that single application of mdr1b/1a siRNA and cyclophosphamide resulted in a decrease in the MDR and a threefold decrease in the tumor size as compared with the control animals treated only with cyclophosphamide, while bcl-2 siRNA was ineffective in vivo.